International
Dragon Pharma Ipamorelin 5 mg Selective GH Secretagogue
Injection · 5 mg · vial
Dragon Pharma Ipamorelin is a 5 mg lyophilized vial of the pentapeptide secretagogue that releases growth hormone without the sharp cortisol and prolactin rise seen with GHRP-2 and GHRP-6. It is sold as research material and the 5 mg fill is the only pack option on this page.
GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. Ipamorelin for sale with U.S. domestic and international shipping.
Product overview
Dragon Pharma Ipamorelin 5 mg Pentapeptide Vial
Ipamorelin is a five amino acid ghrelin receptor agonist developed as the selective option among the growth hormone secretagogues: it releases growth hormone, and in the original swine work it did not raise ACTH or cortisol, which is exactly the opposite of GHRP-2 and GHRP-6. Its clinical program never produced an approval, and the phase II attempt in postoperative ileus was discontinued, so the vial is supplied as laboratory research material in a single 5 mg size.
- 5 mg lyophilized powder per vial, one pack option
- Selective ghrelin receptor agonist, development code NNC 26-0161
- GMP-manufactured and HPLC-verified, COA per batch
- U.S. domestic and international shipping options
How Ipamorelin Works
The peptide binds the ghrelin receptor on the pituitary and produces a growth hormone pulse while leaving the stress axis comparatively quiet, which is the property that separates it from GHRP-2 and GHRP-6. Healthy-volunteer pharmacokinetics give a terminal half-life around two hours, a clearance of 0.078 L/h/kg and a growth hormone peak at 0.67 h, with dose-proportional behavior. That two-hour window is why the peptide is usually combined with a GHRH analogue rather than run alone.
Reconstitution & Research Use
Add bacteriostatic water down the glass wall of the vial and swirl, never shake. Five milligrams with 2 ml gives 2.5 mg/ml, so 0.1 ml carries 250 mcg and reads as 10 units on a U-100 insulin syringe. Vendor material describes 200 to 300 mcg per injection, two or three times a day, on an empty stomach and at least two hours after food, over courses of twelve to sixteen weeks with a break afterwards. Pairing options in the catalog are the ready-made CJC-1295 no DAC blend or the Ipamorelin / Tesamorelin vial, both research material. Reported side effects for the class include injection-site reactions, fluid retention and joint aches.
Quality & Authenticity
Each batch is produced under GMP conditions and checked by HPLC, with a Certificate of Analysis held for the batch. Keep the sealed powder at 2-8 C away from light and refrigerate the mixed solution.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Brand | Dragon Pharma |
| Active Substance | Ipamorelin |
| Dosage | 5 mg per vial |
| Package | 1 lyophilized vial |
| Form | Freeze-dried powder, requires reconstitution |
| Drug Class | Research peptide, GH secretagogue |
| Manufacturing | GMP-certified |
| Testing | HPLC per batch, COA on file |
| Shipping | U.S. domestic and international |
Stacks
FAQ
Before you ask
Questions, answered
Ipamorelin is a pentapeptide ghrelin receptor agonist built to release growth hormone without the extra hormonal noise. In the original swine research it was the first secretagogue that did not raise ACTH or cortisol, unlike GHRP-6 and GHRP-2, which is where the word selective comes from. It has no approved human indication and is sold as research material.
About two hours, measured in healthy volunteers, with a clearance of 0.078 L per hour per kilogram, a volume of distribution of 0.22 L/kg and a growth hormone peak at 0.67 h. Doses behaved proportionally in that work. The two-hour window is short enough that daily or twice-daily timing matters, and it is the reason the peptide is usually paired with a longer GHRH arm.
Add bacteriostatic water slowly down the glass wall and swirl, never shake. Five milligrams with 2 ml gives 2.5 mg/ml, so 0.1 ml equals 250 mcg and reads as 10 units on a U-100 insulin syringe. Vendor and community material describes 200 to 300 mcg per injection, two or three times a day, on an empty stomach, but those numbers are conventions rather than an approved dose.
Class signals for growth hormone secretagogues are injection-site reactions, fluid retention and swelling, joint aches and reduced glucose tolerance, with appetite increase less pronounced than for GHRP-6. No hepatic data exists for the peptide. WADA class S2 names ipamorelin among growth hormone secretagogues and prohibits it at all times, so a tested athlete should treat any use as a positive.
The 5 mg vial is listed on this page as research material with U.S. domestic and international shipping, and price and stock appear against the option selector above. Keep the sealed powder at 2-8 C away from light, do not let it freeze, and hold the reconstituted solution in the refrigerator, using it within about four weeks.
Be the first to share your experience with Dragon Pharma Ipamorelin 5 mg Selective GH Secretagogue
Log in to write a reviewComplete the cycle
Stack it with
International
International
Available Domestic
International
Available Domestic